Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Zeltia SA    ZEL   ES0184940817

ZELTIA SA (ZEL)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Zeltia SA
Operates as a biopharmaceutical company

Zeltia SA is a biopharmaceutical company, which specialized in the development of marine-based drugs for use in oncology.

The company operates through two main segments: Biopharmaceuticals and Consumer Chemicals.

The Biopharmaceuticals segment engages in the research, development and marketing of antitumor drugs through Pharma Mar SAU, the development and marketing of diagnosis kits through Genómica SAU and the development of therapies based on reducing or silencing gene expression through Sylentis SA. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products through various subsidiaries, which include Zelnova SA, Xylazel SA and Copyr SpA. Zeltia was founded on August 3, 1939 and is headquartered in Madrid, Spain.
Managers
NameAgeSinceTitle
José Maria Fernández de Sousa-Faro PhD, MBA-1971Chairman & Chief Executive Officer
Maria Luisa de Francia--Chief Financial Officer
Pedro Fernández Puentes-1971Vice Chairman
José Luis Fernández Puentes, PhD--Director
Santiago Alfredo Fernández Puentes--Director
José Antonio de Urquizu Iturrarte, MBA-1991Independent Director
Jaime Zurita Sáenz de Navarrete, LLD--Director
José Félix Pérez-Orive Carceller, MBA-1990Independent Director
Eduardo Serra Rexach68-Independent Director
Carlos Solchaga Catalán70-Director
Shareholders
NameShares%
José Maria Fernández de Sousa-Faro, PhD, MBA 14,269,5116.42%
Estate of Mera Goyenechea Rosalia 11,110,3335.00%
Montserrat Andrade Detrell 10,254,8414.62%
Safoles SA 8,615,2053.88%
Norges Bank Investment Management 6,383,2892.87%
Kutxabank SA 4,671,0002.10%
JPMorgan Asset Management (UK) Ltd. 3,339,6011.50%
José Luis Fernández Puentes, PhD 3,209,4261.44%
Santiago Alfredo Fernández Puentes 3,074,8101.38%
Dimensional Fund Advisors LP 1,507,2060.68%
Holdings
NameShares%Valuation
Zeltia SA (ZEL) 1,326,2510.60%4,774,848 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
PHARMACYCLICS, IN..
ALKERMES PLC
PUMA BIOTECHNOLOG..
-
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
UNITED THERAPEUTI..
QIAGEN NV
ISIS PHARMACEUTIC..
COVANCE INC.
SEATTLE GENETICS,..
TECHNE CORPORATIO..
ICON PLC
PAREXEL INTERNATI..
CHARLES RIVER LAB..
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
SYNAGEVA BIOPHARM..
MORPHOSYS AG
BB BIOTECH AG
Sector Biotechnology & Medical Research
Company contact information
Zeltia SA
Plaza Descubridor Diego de Ordás, 3
Planta 5
Madrid 28003

Phone : +34.91.444.45.00
Fax : +34.91.593.29.94
Web : www.zeltia.es
© 2014 Factset   
Dynamic quotes  
ON
| OFF